Company: PSTV
Filing Date: 2025-07-21
Form Type: DEF 14A
Source: 0001140361-25-026611
Chunk: 67

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-21
Form: DEF 14A
Chunk 67
---
 us under the Lincoln Park Purchase Agreement, we would need to issue 157,728,707 and 500,000,000 shares of Common Stock, respectively, to Lincoln Park, which in each case would be in excess of the Nasdaq 20% Rule. Accordingly, in order to be able to sell to Lincoln Park the full amount available under the Lincoln Park Purchase Agreement at a price less than the LP Minimum Price, we are seeking stockholder approval to issue greater than 20% of our outstanding shares as of the date we entered into the agreement with Lincoln Park, which issuance would be effected under the Lincoln Park Purchase Agreement in accordance with its terms. 40 TABLE OF CONTENTS Effect of Failure to Obtain Stockholder Approval If the stockholders do not approve this proposal, then we will be unable to issue shares of Common Stock to Lincoln Park pursuant to the Lincoln Park Purchase Agreement in excess of the Exchange Cap if sold at a price less than the LP Minimum Price. Effect of Approval If we obtain stockholder approval as requested in this proposal, then we would no longer be subject to the Nasdaq 20% Rule restriction with respect to the issuance and sale of Common Stock to Lincoln Park under the Lincoln Park Purchase Agreement. If this proposal is approved by our stockholders, we would be able to issue more than the Exchange Cap (or 10,194,593 shares) to Lincoln Park under the Lincoln Park Purchase Agreement at a price less than the LP Minimum Price. The maximum number of shares of Common Stock that we may issue and sell to Lincoln Park under the Lincoln Park Purchase Agreement would fluctuate from time to time based on the price of our Common Stock. Assuming that our stockholders approve this proposal, and assuming and the total number of shares issuable under the Lincoln Park Purchase Agreement were issued on July 15, 2025 at the closing price on that date and at the Floor Price, a total of 157,728,707 additional shares of Common Stock and 500,000,000 shares of Common Stock, respectively, would be issuable to Lincoln Park, which have an approximate value of $50 million. In addition, these additional shares of Common Stock that we could issue to Lincoln Park will result in greater dilution to existing stockholders and may result in a decline in our stock price or greater price volatility. Each such additional share of Common Stock that would be issuable to Lincoln Park under the Lincoln Park Purchase Agreement would have the same rights and privileges as each share of our currently authorized Common Stock. Vote Required and